During the past decade, Hospital Joaquim Urbano conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Joaquim Urbano" #1 collaborator was "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Joaquim Urbano" are "HIV Infections" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Hospital Joaquim Urbano" in a lesser frequency.

Most popular intervention types in "Hospital Joaquim Urbano" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pulmonary function Testing" (1 trials) and "tiotropium bromide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Joaquim Urbano" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Joaquim Urbano". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Joaquim Urbano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Joaquim Urbano, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".